Synthesis of New Quinolinequinone Derivatives and Preliminary Exploration of their Cytotoxic Properties

Charles M. Keyari, Alison K. Kearns, Nathan S. Duncan, Emily A. Eickholt, Geoffrey Abbott, Howard D. Beall, Philippe Diaz

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


A series of 7-amino- and 7-acetamidoquinoline-5,8-diones with aryl substituents at the 2-position were synthesized, characterized, and evaluated as potential NAD(P)H:quinone oxidoreductase (NQO1) -directed antitumor agents. The synthesis of lavendamycin analogues is illustrated. Metabolism studies demonstrated that 7-amino analogues were generally better substrates for NQO1 than 7-amido analogues, as were compounds with smaller heteroaromatic substituents at the C-2 position. Surprisingly, only two compounds, 7-acetamido-2-(8′-quinolinyl)quinoline-5,8-dione (11) and 7-amino-2-(2-pyridinyl)quinoline-5,8-dione (23), showed selective cytotoxicity toward the NQO1-expressing MDA468-NQ16 breast cancer cells versus the NQO1-null MDA468-WT cells. For all other compounds, NQO1 protected against quinoline-5,8-dione cytotoxicity. Compound 22 showed potent activity against human breast cancer cells expressing or not expressing NQO1, with respective IC50 values of 190 nM and 140 nM and a low NQO1-mediated reduction rate, which suggests that the mode of action of 22 differs from that of lavendamycin and involves an unidentified target(s).

Original languageEnglish
Pages (from-to)3806-3819
Number of pages14
JournalJournal of Medicinal Chemistry
Issue number10
StatePublished - May 23 2013


Dive into the research topics of 'Synthesis of New Quinolinequinone Derivatives and Preliminary Exploration of their Cytotoxic Properties'. Together they form a unique fingerprint.

Cite this